| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration Bmj 324 (7329), 71-86, 2002 | 13595* | 2002 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8555* | 2005 |
| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators New England Journal of Medicine 345 (7), 494-502, 2001 | 8114 | 2001 |
| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 7981 | 2017 |
| Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events DL Bhatt, KAA Fox, W Hacke, PB Berger, HR Black, WE Boden, P Cacoub, ... New England Journal of Medicine 354 (16), 1706-1717, 2006 | 3870 | 2006 |
| Predictors of hospital mortality in the global registry of acute coronary events CB Granger, RJ Goldberg, O Dabbous, KS Pieper, KA Eagle, CP Cannon, ... Archives of internal medicine 163 (19), 2345-2353, 2003 | 3043 | 2003 |
| ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary a report of the American College of Cardiology/American Heart Association task … Committee Members, V Fuster, LE Rydén, RW Asinger, DS Cannom, ... Circulation 104 (17), 2118-2150, 2001 | 2934* | 2001 |
| European Society of Cardiology: cardiovascular disease statistics 2019 A Timmis, N Townsend, CP Gale, A Torbica, M Lettino, SE Petersen, ... European heart journal 41 (1), 12-85, 2020 | 2735 | 2020 |
| Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) MD Flather, MC Shibata, AJS Coats, DJ Van Veldhuisen, A Parkhomenko, ... European heart journal 26 (3), 215-225, 2005 | 2333 | 2005 |
| Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients MD Flather, S Yusuf, L Køber, M Pfeffer, A Hall, G Murray, ... The Lancet 355 (9215), 1575-1581, 2000 | 2319 | 2000 |
| Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE) KAA Fox, OH Dabbous, RJ Goldberg, KS Pieper, KA Eagle, F Van de Werf, ... bmj 333 (7578), 1091, 2006 | 2117 | 2006 |
| A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry KA Eagle, MJ Lim, OH Dabbous, KS Pieper, RJ Goldberg, F Van de Werf, ... Jama 291 (22), 2727-2733, 2004 | 2100 | 2004 |
| Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials … PR Collins R, Flather M, Parish S, Baigent C The Lancet 343, 311-322, 1994 | 1664 | 1994 |
| Apixaban with antiplatelet therapy after acute coronary syndrome JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ... New England Journal of Medicine 365 (8), 699-708, 2011 | 1330 | 2011 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1214 | 2017 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1191 | 2010 |
| Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 KAA Fox, PG Steg, KA Eagle, SG Goodman, FA Anderson, CB Granger, ... Jama 297 (17), 1892-1900, 2007 | 1145 | 2007 |
| Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial DL Bhatt, MD Flather, W Hacke, PB Berger, HR Black, WE Boden, ... Journal of the American College of Cardiology 49 (19), 1982-1988, 2007 | 1027 | 2007 |
| Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten … MA Hlatky, DB Boothroyd, DM Bravata, E Boersma, J Booth, MM Brooks, ... The lancet 373 (9670), 1190-1197, 2009 | 962 | 2009 |
| Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable anginal and non-Q-wave myocardial infarction PRISM-Plus Investigators N Engl J Med. 338, 1488-1497, 1998 | 922 | 1998 |
